Inventor · disambiguated record
Luke Jonathan Alvey
Also filed as: ALVEY LUKE JONATHAN
19 granted patents·3 pending applications·40 citations·filing 2012–2022
92Inventor score
Top patents by PatentIndex Score
22 records- 0190US9926281B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2015·Granted Mar 27, 2018·6 cites·18 claims
- 0288US10487060B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2018·Granted Nov 26, 2019·4 cites·28 claims
- 0386US10259810B2N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2017·Granted Apr 16, 2019·5 cites·8 claims
- 0485US8927543B2Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2012·Granted Jan 6, 2015·6 cites·9 claims
- 0584US9890158B2N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2016·Granted Feb 13, 2018·5 cites·50 claims
- 0684US9255095B2Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2014·Granted Feb 9, 2016·6 cites·15 claims
- 0780US11339166B2Compounds and pharmaceutical compositions thereof for the treatment of diseasesGALAPAGOS NV·Filed 2018·Granted May 24, 2022·2 cites·20 claims
- 0879US10047083B2Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2015·Granted Aug 14, 2018·2 cites·16 claims
- 0976US10647717B2N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2019·Granted May 12, 2020·1 cites·3 claims
- 1074US2022227751A1Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders.GALAPAGOS NV·Filed 2021·Application pending·0 cites
- 1173US9796711B2Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and method of useABBVIE S ÀR L·Filed 2016·Granted Oct 24, 2017·2 cites·42 claims
- 1269US11718588B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2021·Granted Aug 8, 2023·0 cites·16 claims
- 1369US9708312B2Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders (GPR84 antagonists)GALAPAGOS NV·Filed 2013·Granted Jul 18, 2017·1 cites·17 claims
- 1468US10941117B25-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2019·Granted Mar 9, 2021·0 cites·4 claims
- 1566US12065443B2Compounds and pharmaceutical compositions thereof for the treatment of diseasesGALAPAGOS NV·Filed 2022·Granted Aug 20, 2024·0 cites·29 claims
- 1662US11220499B2Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2018·Granted Jan 11, 2022·0 cites·20 claims
- 1759US2019202823A1N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USEABBVIE SARL·Filed 2019·Application pending·0 cites
- 1846US2018016275A1Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders (gpr84 antagonists)GALAPAGOS NV·Filed 2017·Application pending·0 cites
- 1941US12391679B2Benzamide-substituted bicyclic imidazo- and pyrazolo-fused -pyridine, -pyrimide, and -pyridazine compounds for treatment of inflammatory diseasesONCO3R THERAPEUTICS BV·Filed 2020·Granted Aug 19, 2025·0 cites·15 claims
- 2038US10829478B25-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritisGALAPAGOS NV·Filed 2017·Granted Nov 10, 2020·0 cites·37 claims
- 2137US10550100B25-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritisGALAPAGOS NV·Filed 2017·Granted Feb 4, 2020·0 cites·15 claims
- 2235US10130622B2Compounds for treatment of cystic fibrosisABBVIE SARL·Filed 2016·Granted Nov 20, 2018·0 cites·33 claims
Join the waitlist — get patent alerts
Get an alert when Luke Jonathan Alvey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →